Curaleaf Holdings (CURLF) Long-Term Deferred Tax (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Long-Term Deferred Tax of $443000.0 for Q4 2025, up 10.47% year-on-year from $401000.0 in Q4 2024, and up 10.47% on a QoQ basis from $401000.0 in Q4 2024.

Curaleaf Holdings (CURLF) Long-Term Deferred Tax (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Long-Term Deferred Tax for 7 consecutive years, with $443000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 10.47% year-over-year to $443000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $443000.0 (up 10.47% YoY) and the FY2025 annual result came in at $443000.0, up 10.47% from the prior year.
  • Long-Term Deferred Tax grew to $443000.0 in Q4 2025 per CURLF's latest filing, from $401000.0 in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for CURLF reached as high as $2.7 billion in Q1 2022 and fell as low as $382000.0 in Q3 2021.
  • A 5-year average of $180.2 million and a median of $1.6 million in 2022 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2021 — Long-Term Deferred Tax plunged 85.78% — and 2022, when it soared 48290.01%.
  • Year by year, Long-Term Deferred Tax stood at $2.2 million in 2021, then decreased by 27.42% to $1.6 million in 2022, then slumped by 73.21% to $419000.0 in 2023, then dropped by 4.3% to $401000.0 in 2024, then climbed by 10.47% to $443000.0 in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $443000.0, $401000.0, and $594000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 443,000.00
Dec 31, 2024 401,000.00
Sep 30, 2024 594,000.00
Jun 30, 2024 1.22 Mn
Dec 31, 2023 419,000.00
Sep 30, 2023 1.69 Mn
Jun 30, 2023 1.29 Mn
Dec 31, 2022 1.56 Mn
Sep 30, 2022 3.47 Mn
Jun 30, 2022 2.98 Mn
Mar 31, 2022 2.68 Bn
Dec 31, 2021 2.16 Mn
Sep 30, 2021 382,000.00
Jun 30, 2021 6.27 Mn
Mar 31, 2021 5.53 Mn
Dec 31, 2020 5.53 Mn
Sep 30, 2020 2.69 Mn
Dec 31, 2019 2.63 Mn